Understanding and making use of human memory B cells

Immunological Reviews

Volumn 211, Issue , 2006, Pages 303-309

  Lanzavecchia, Antonio ^a   Bernasconi, Nadia ^a   Traggiai, Elisabetta ^a   Ruprecht, Claudia R ^a   Corti, Davide ^a   Sallusto, Federica ^a  

^a INSTITUTE FOR RESEARCH IN BIOMEDICINE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; MONOCLONAL ANTIBODY;

ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; B LYMPHOCYTE ACTIVATION; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; IN VITRO STUDY; MEMORY CELL; PLASMA CELL; PRIORITY JOURNAL; REVIEW; VACCINATION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY-PRODUCING CELLS; B-LYMPHOCYTES; HUMANS; IMMUNIZATION, SECONDARY; IMMUNOLOGIC MEMORY; LYMPHOCYTE ACTIVATION; MICE; TOLL-LIKE RECEPTORS; VACCINATION;

EID: 33745109928     PISSN: 01052896     EISSN: 1600065X     Source Type: Journal    
DOI: 10.1111/j.0105-2896.2006.00403.x     Document Type: Review

References (40)

1. Mills DM Cambier JC. B lymphocyte activation during cognate interactions with CD4+ T lymphocytes: molecular dynamics and immunologic consequences. Semin Immunol 2003 15: 325 329.
2. Parker DC. T cell-dependent B cell activation. Annu Rev Immunol 1993 11: 331 360.
3. Banchereau J, et al. The CD40 antigen and its ligand. Annu Rev Immunol 1994 12: 881 922.
4. Manz RA Hauser AE Hiepe F Radbruch A. Maintenance of serum antibody levels. Annu Rev Immunol 2005 23: 367 386.
5. Klein U Rajewsky K Kuppers R. Human immunoglobulin (Ig)M+IgD+ peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells. J Exp Med 1998 188: 1679 1689.
6. Wirths S Lanzavecchia A. ABCB1 transporter discriminates human resting naive B cells from cycling transitional and memory B cells. Eur J Immunol 2005 35: 3433 3441.
7. Lanzavecchia A. One out of five peripheral blood B lymphocytes is activated to high- rate Ig production by human alloreactive T cell clones. Eur J Immunol 1983 13: 820 824.
8. Lanzavecchia A Parodi B Celada F. Activation of human B lymphocytes: frequency of antigen-specific B cells triggered by alloreactive or by antigen-specific T cell clones. Eur J Immunol 1983 13: 733 738.
9. Kindler V Zubler RH. Memory, but not naive, peripheral blood B lymphocytes differentiate into Ig-secreting cells after CD40 ligation and costimulation with IL-4 and the differentiation factors IL-2, IL-10, and IL-3. J Immunol 1997 159: 2085 2090.
10. Tangye SG Avery DT Deenick SK Hodgkin PD. Intrinsic differences in the proliferation of naive and memory human B cells as a mechanism for enhanced secondary immune responses. J Immunol 2003 170: 686 694.
11. Bernasconi NL Traggiai E Lanzavecchia A. Maintenance of serological memory by polyclonal activation of human memory B cells. Science 2002 298: 2199 2202.
12. Bernasconi NL Onai N Lanzavecchia A. A role for Toll-like receptors in acquired immunity: up-regulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cells. Blood 2003 101: 4500 4504.
13. Ruprecht C Lanzavecchia A. TLR stimulation as a third signal required for activation of human naive B cells. Eur J Immunol 2006 36: 810 816.
14. Pasare C Medzhitov R. Control of B-cell responses by Toll-like receptors. Nature 2005 438: 364 368.
15. Coutinho A Gronowicz E Bullock WW Moller G. Mechanism of thymus-independent immunocyte triggering. Mitogenic activation of B cells results in specific immune responses. J Exp Med 1974 139: 74 92.
16. Krieg AM, et al. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 1995 374: 546 549.
17. McHeyzer-Williams MG Ahmed R. B cell memory and the long-lived plasma cell. Curr Opin Immunol 1999 11: 172 179.
18. Manz RA Thiel A Radbruch A. Lifetime of plasma cells in the bone marrow. Nature 1997 388: 133 134.
19. Slifka MK Antia R Whitmire JK Ahmed R. Humoral immunity due to long-lived plasma cells. Immunity 1998 8: 363 372.
20. Zinkernagel RM. On differences between immunity and immunological memory. Curr Opin Immunol 2002 14: 523 536.
21. Ochsenbein AF Pinschewer DD Sierro S Horvath E Hengartner H Zinkernagel RM. Protective long-term antibody memory by antigen-driven and T help-dependent differentiation of long-lived memory B cells to short-lived plasma cells independent of secondary lymphoid organs. Proc Natl Acad Sci USA 2000 97: 13263 13268.
22. Putz MM Alberini I Midgley CM Manini I Montomoli E Smith GL. Prevalence of antibodies to Vaccinia virus after smallpox vaccination in Italy. J Gen Virol 2005 86: 2955 2960.
23. Crotty S Felgner P Davies H Glidewell J Villarreal L Ahmed R. Cutting edge: long-term B cell memory in humans after smallpox vaccination. J Immunol 2003 171: 4969 4973.
24. Odendahl M, et al. Generation of migratory antigen-specific plasma blasts and mobilization of resident plasma cells in a secondary immune response. Blood 2005 105: 1614 1621.
25. Macallan DC, et al. B-cell kinetics in humans: rapid turnover of peripheral blood memory cells. Blood 2005 105: 3633 3640.
26. O'Connor BP Cascalho M Noelle RJ. Short-lived and long-lived bone marrow plasma cells are derived from a novel precursor population. J Exp Med 2002 195: 737 745.
27. Shapiro-Shelef M Lin KI McHeyzer-Williams LJ Liao J McHeyzer-Williams MG Calame K. Blimp-1 is required for the formation of immunoglobulin secreting plasma cells and pre-plasma memory B cells. Immunity 2003 19: 607 620.
28. Uhr JW Moller G. Regulatory effect of antibody on the immune response. Adv Immunol 1968 8: 81 127.
29. Kohler G Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 1975 256: 495 497.
30. Steinitz M Klein G Koskimies S Makel O. EB virus-induced B lymphocyte cell lines producing specific antibody. Nature 1977 269: 420 422.
31. Kozbor D Roder JC. Requirements for the establishment of high-tittered human monoclonal antibodies against tetanus toxoid using the Epstein-Barr virus technique. J Immunol 1981 127: 1275 1280.
32. Lanzavecchia A. Antigen-specific interaction between T and B cells. Nature 1985 314: 537 539.
33. Jones PT Dear PH Foote J Neuberger MS Winter G. Replacing the complementarity-determining regions in a human antibody with those from a mouse. Nature 1986 321: 522 525.
34. McCafferty J Griffiths AD Winter G Chiswell DJ. Phage antibodies: filamentous phage displaying antibody variable domains. Nature 1990 348: 552 554.
35. Green LL. Antibody engineering via genetic engineering of the mouse: XenoMouse strains are a vehicle for the facile generation of therapeutic human monoclonal antibodies. J Immunol Methods 1999 231: 11 23.
36. Brekke OH Sandlie I. Therapeutic antibodies for human diseases at the dawn of the twenty-first century. Nat Rev Drug Discov 2003 2: 52 62.
37. Johnson S, et al. Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus. J Infect Dis 1997 176: 1215 1224.
38. Traggiai E, et al. An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus. Nat Med 2004 10: 871 875.
39. Yang ZY, et al. Evasion of antibody neutralization in emerging severe acute respiratory syndrome coronaviruses. Proc Natl Acad Sci USA 2005 102: 797 801.
40. Pantophlet R Burton DR. GP120: target for neutralizing HIV-1 antibodies. Annu Rev Immunol 2006 24: 739 769.